Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
Why Is American Well Corporation (AMWL) Stock Down -12.08% Today?

Why Is American Well Corporation (AMWL) Stock Down -12.08% Today?

Key Takeaways

  • AMWL shares were down roughly 12% in Friday's session, reversing the prior day's sharp advance.
  • The pullback reflects broad profit-taking after a steep multi-week rally that pushed the stock well above consensus analyst price targets.
  • Investors appear to be de-risking ahead of the company's third-quarter earnings report, scheduled for after the close on November 3.
  • The move diverges from a relatively stable broader market and is concentrated in the small-cap telehealth name rather than the wider healthcare sector.
  • Traders are watching next week's earnings, subscription revenue trends, and the path toward cash-flow breakeven as key catalysts.
  • For deeper analysis, explore Price Targets, Earnings, and Forecast data on additional pages.
  • Discover actionable trading ideas with Tickeron's Trending AI Robots.

Opening Summary

American Well Corporation (AMWL), doing business as Amwell, is a Boston-based digital care enablement company that connects providers, payers, and patients through its hybrid-care and virtual-health platform. In Friday's session, the stock fell about 12.08% to roughly $13.17, down from Thursday's closing price of $14.98. The decline represents a sharp reversal of the 6% gain booked in the prior session and underscores how quickly momentum can unwind in a small-cap name that has run far ahead of fundamental expectations.

Profit-Taking After a Parabolic Rally

The most direct driver of Friday's decline appears to be profit-taking following an extended run-up. AMWL shares have climbed dramatically from their 52-week low of $3.71, more than tripling in value as investors rewarded the company's improving cost discipline and growing backlog of government and enterprise contracts. When a stock appreciates that quickly, even the absence of negative news can trigger sharp reversals, as traders lock in gains and momentum strategies unwind. Friday's double-digit slide fits the pattern of a mean-reversion move in an overheated rally rather than a fundamental breakdown.

Valuation Running Ahead of Analyst Targets

A key point of tension in the market is that AMWL had traded well above the consensus view of Wall Street. Most analysts maintain a "Hold" rating, and average 12-month price targets have remained meaningfully below the stock's recent highs. The gap between the share price and sell-side targets made the stock vulnerable to a correction, and Friday's move can be seen as the market bringing the price back toward a level more consistent with near-term estimates. The company's revenue base is still contracting as it transitions toward its Converge software platform, a dynamic that complicates a valuation case built primarily on momentum.

De-Risking Ahead of Third-Quarter Earnings

Timing also matters. Amwell is scheduled to report third-quarter results after the market closes on Tuesday, November 3, and investors frequently trim positions into a print they perceive as uncertain. Analysts expect quarterly revenue of roughly $47 million, down approximately 16% year over year, even as the company continues to narrow its losses. While Amwell raised its full-year profitability outlook earlier in the year and has signaled progress toward operating and cash-flow breakeven, shrinking subscription and top-line revenue remain headwinds. With the stock having already surged on earnings anticipation, the risk-reward setup heading into the report appears less favorable, prompting some holders to sell before the news.

Market Context and Trading Activity

The decline in AMWL was largely idiosyncratic rather than a reflection of broad market weakness. Major equity indices were not moving in sympathy with the double-digit drop, suggesting the selling was concentrated in the stock itself. Trading activity has been elevated in recent sessions, with volume running well above the company's typical daily average as the rally attracted speculative interest. After Thursday's higher-than-average turnover, Friday's pullback likely reflected aggressive unwinding of that same short-term positioning. The stock's high beta and historically thin float amplify both up and down moves, making sharp swings like this more common.

What Comes Next for AMWL

The immediate focus is next week's third-quarter earnings report and management's commentary on the fourth-quarter path to cash-flow breakeven. Investors will scrutinize subscription revenue trends, gross margins, and any update on the company's government opportunities, including the letter of intent from the Department of Veterans Affairs and its defense health contracts. Analyst expectations remain cautious, and the direction of the stock may hinge on whether the company can demonstrate durable revenue stabilization alongside continued cost control. Key risks include further insider selling, ongoing top-line contraction during the platform transition, and the possibility that valuation remains stretched relative to fundamentals. As always, single-session moves in a low-float, high-volatility stock should be viewed in the context of the broader multi-week trend.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that have demonstrated strength under current market conditions. Tickeron offers hundreds of automated trading bots covering thousands of tickers, each differing in strategy, timeframe, performance metrics, and traded symbols. Only the strongest performers are featured in the Trending AI Robots section, giving traders a focused way to explore quantitative approaches to the market. To see which strategies are currently leading, visit the Trending AI Robots page and discover tools that may complement your own research.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMWL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AMWL in upward trend: 10-day moving average broke above 50-day moving average on October 23, 2026

The 10-day moving average for AMWL crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on AMWL as a result. In 69 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for AMWL just turned positive on October 21, 2026. Looking at past instances where AMWL's MACD turned positive, the stock continued to rise in 29 of 38 cases over the following month. The odds of a continued upward trend are 76%.

AMWL moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +10.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMWL advanced for three days, in 181 of 234 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMWL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

AMWL broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AMWL entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.152) is normal, around the industry mean (4.731). P/E Ratio (-3.134) is within average values for comparable stocks, (13.055). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (1.006) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AMWL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMWL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 3.28B. The market cap for tickers in the group ranges from 708 to 50.25B. VEEV holds the highest valuation in this group at 50.25B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was 2%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 16%. TDOC experienced the highest price growth at 38%, while ZCMD experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 47%. For the same stocks of the Industry, the average monthly volume growth was 51% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 53
Price Growth Rating: 53
SMR Rating: 86
Profit Risk Rating: 96
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
AMWL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Industry
N/A
Address
75 State Street
Phone
+1 617 204-3500
Employees
562
Web
https://business.amwell.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.